Risperidone에서 Clozapine으로 교체 도중 발생한 비정형 신경이완제 악성 증후군 1예 = A Case of Atypical Neuroleptic Malignant Syndrome Which Occurred during Switching from Risperidone to Clozapine

다국어 초록 (Multilingual Abstract)

Neuroleptic malignant syndrome(NMS) is rare but a potentially fatal side effect of antipsychotics. It is characterized by muscular rigidity, fever, autonomic instability, and altered consciousness. Because it may be a possible result of a precipitous reduction in dopamine receptor activation, the introduction of the atypical antipsychotics raised expectations that these drugs would not cause NMS. But many NMS cases associated with atypical antipsychotics, including clozapine, have been reported so far. We experienced a case of NMS which is thought to be caused by the use of clozapine. The patient was a 30 year-old man, and he has suffered for 13 years from disorganized schizophrenia with bizarre delusion, auditory hallucination and disorganized behavior. He was treated with various antipsychotics but none of them were effective enough to control the symptoms, so the drug was switched from risperidone to clozapine. We titrated clozapine up to 225㎎/d and tapered off risperidone to 1㎎/d, and physical and neurological condition were normal. On 27th days of clozapine treatment, the patient suddenly developed clouding of consciousness, tremor, severe muscular rigidity and enuresis, so all the medications were stopped. On the 29th days of clozapine treatment, the laboratory test showed abnormal results：creatine phosphokinase(CPK) 128IU/I, lactate dehydrogenase( LDH) 508 IU/I, aspartate aminotransferase(AST) 110IU/I, alanine aminotransferase(ALT) 116IU/I, and white blood cell(WBC) 13.7×10³/μL. The patient was treated with benztropine 3㎎/d and diazepam 10㎎/d, and his condition improved to show no sign of muscular rigidity and disorientation within a week, and the laboratory tests were normal including WBC, CPK and LDK. Five days later, the patient had sudden seizure attacks but there were nothing abnormal on magnetic resonance imaging scan, electrolytes and neurological tests. He started taking valproate, and afterward he had nothing abnormal on blood tests and neurological examinations with no seizure attacks.

목차 (Table of Contents)

• 서론
• 증례
• 고찰
• 결론
• 참고문헌

참고문헌 (Reference)

• 1 Delay J, "Un Neuroleptique majeur nonphenothiazine et non-reserpinique, l'haloperidol, dans le traitement des psychoses" 118 : 145-52, 1960
• 2 Caroff, "The neuroleptic malignant syndrome" 41 : 79-83, 1980
• 3 Levenson JL, "The neuroleptic malignant syndrome" 142 : 1137-45, 1985
• 4 Supe S, "Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome-a case report" 18 : 97-101, 2006
• 5 Keck PE, "Risk factors for neuroleptic malignant syndrome" 46 : 914-918, 1989
• 6 Atbasoglu EC, "Rhabdomyolysis and coma associated with amisulpride:a probable atypical presentation of neuroleptic malignant syndrome" 65 : 1724-1725, 2004
• 7 Duggal HS, "Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine" 162 : 397-398, 2005
• 8 Kontaxakis VP, "Olanzapine-associated neuroleptic malignant syndrome" 26 : 897-902, 2002
• 9 Hasan S, "Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique" 155 : 1113-1116, 1998
• 10 Whalley N, "Neuroleptic malignant syndrome associated with the use of quetiapine" 52 : 112-, 1999
• 11 Tsai G, "Neuroleptic malignant syndrome associated with clozapine treatment" 7 : 91-95, 1995
• 12 Pope HG Jr, "Frequency and presentation of neuroleptic malignant syndrome" 1344-6, amjpsychiatry1987
• 13 Tarsy D, "Effects of newer antipsychotics on extrapyramidal function" 16 : 23-45, 2002
• 14 American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" text revision. Washington DC: American Psychiatric Press 795-798, 2000
• 15 Karagianis JL, "Clozapine-associated neuroleptic maligannt syndrome:two case and a review of the literature" 33 : 623-630, 1999
• 16 김찬형, "Clozapine 중단 과정에서 반동정신병 발병 이후 유발된 비정형적 신경이완제 악성증후군" 9 : 188-192, 1998
• 17 Niesen J, "Atypical neuroleptic malignant syndrome caused by olanzapine" 112 : 238-240, 2005
• 18 Nopoulos P, "Atypical neuroleptic malignant syndrome (NMS) with atypical neuroleptic: clozapine-induced NMS without rigidity" (poulos p) : 251-3,
• 19 Caroff SN, "Atypical antipsychotics and the neuroleptic malignant syndrome" 30 : 314-321, 2000
• 20 Cohen S, "A case of nonneuroleptic malignant syndrome" 48 : 287-8, 1987